(a) If the FFD program follows splitspecimen procedures, as described in §26.113, the licensee testing facility shall analyze aliquots of the specimen for the licensee’s or other entity’s purposes as described in this part. Except as provided in paragraph (b) in this section, the licensee testing facility shall store Bottles A and B of the specimen in a secure manner until the facility has finished testing. If the initial validity and drug test results are negative and the specimen in Bottle A will not be forwarded to the HHS-certified laboratory, the licensee testing facility may discard both Bottle A and Bottle B. If any test results are positive or indicate that the specimen is of questionable validity, the licensee testing facility shall forward Bottle A to the HHScertified laboratory for testing and shall retain Bottle B in secure storage, under the requirements of §26.159(i), or may forward it to the HHS-certified laboratory for storage.